Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 6Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 163Recruiting 81Unknown 60Terminated 39Active not recruiting 24Not yet recruiting 20Withdrawn 19Enrolling by invitation 3Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 19Breast 15CNS 14Genitourinary 9Head & Neck 7Lymphoid 6Other solid neoplasm 5Other hematologic neoplasm 4Other 4Gynecologic 4Dermatologic 3Tumor-Agnostic 2Plasma cell 2Myeloid 2Thoracic 1Sarcoma 1Other neoplasm 1Classical hematology 1

Conditions

Gastrointestinal Stromal Tumors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Suspended × Sarcoma × Clear all
NCT02924714 2022-02-18

SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST

Oslo University Hospital

Phase NA Suspended
31 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡